Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elise Peltekian"'
Autor:
Glenn Dallérac, Caroline Perronnet, Carine Chagneau, Pascale Leblanc-Veyrac, Nathalie Samson-Desvignes, Elise Peltekian, Olivier Danos, Luis Garcia, Serge Laroche, Jean-Marie Billard, Cyrille Vaillend
Publikováno v:
Neurobiology of Disease, Vol 43, Iss 3, Pp 635-641 (2011)
Duchenne muscular dystrophy (DMD) is caused by the absence of dystrophin, a protein that fulfills important functions in both muscle and brain. The mdx mouse model of DMD, which also lacks dystrophin, shows a marked reduction in γ-aminobutyric acid
Externí odkaz:
https://doaj.org/article/ad0169baae5b421f99d7a1086b84a657
Autor:
Rachid Benchaouir, David Israeli, Philippe Rameau, Luis Garcia, Elise Peltekian, Simindokht Ziaei, Olivier Danos, Carole Gruszczynski
Publikováno v:
Journal of Cellular Physiology. 201:409-419
Fibroblast growth factor 6 (FGF6) is selectively expressed during muscle development and regeneration. We examined its effect on muscle precursor cells (mpc) by forcing stable FGF6 expression in C2C12 cells in vitro. FGF6 produced in genetically engi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd4826e512d820fd5ee1b17a9b377a85
https://doi.org/10.1002/jcp.20088
https://doi.org/10.1002/jcp.20088
Publikováno v:
Molecular Therapy. 5:25-32
Viral tropism refers to the ability of a virus to selectively infect a given subset of cells. It relies on a variety of viral and host determinants that entail virus binding and entry into target cells, in addition to the presence of genetic elements
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423d0bced987be311dbbebb544e95b7b
https://doi.org/10.1006/mthe.2001.0517
https://doi.org/10.1006/mthe.2001.0517
Publikováno v:
Cytotechnology. 30:173-180
Gene therapy as a treatment for neuromuscular diseases is an ever-developing concept based on the use of DNA as the therapeutic agent. In the search for appropriate strategies a bottleneck exists, however, concerning the targeting of vectors carrying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7627cdd467a7eeb251fb6acdee6e84dc
https://doi.org/10.1023/a:1008022713466
https://doi.org/10.1023/a:1008022713466
Autor:
Christian Pastoret, Luis Garcia, Elise Peltekian, Nasser Armande, David Israeli, Elaine Parrish
Publikováno v:
The Journal of Gene Medicine. 1:43-55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39378d26e9429b87d41d5596231761e0
https://doi.org/10.1002/(sici)1521-2254(199901/02)1:1<43::aid-jgm7>3.0.co
https://doi.org/10.1002/(sici)1521-2254(199901/02)1:1<43::aid-jgm7>3.0.co
Autor:
Said Akli, Axel Kahn, Emmanuelle Vigne, Elise Peltekian, Fabrice Lisovoski, Michel Perricaudet, Georg Haase, Marc Peschanski, Patrick A. Dreyfus
Publikováno v:
The Journal of Neuroscience. 17:7228-7236
Synthesis of the ciliary neurotrophic factor (CNTF) and its specific receptor (CNTFRα) is widespread in the intact CNS, but potential biological roles for this system remain elusive. Contradictory results have been obtained concerning a possible eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e95c1e288397bc59618cc79b7db3f244
https://doi.org/10.1523/jneurosci.17-19-07228.1997
https://doi.org/10.1523/jneurosci.17-19-07228.1997
Publikováno v:
Journal of Neuroscience Methods. 71:77-84
The purpose of this short review is to analyse major advantages and limitations of the adenovirus (Ad), specifically with relevance to its use as a vector for gene transfer to the brain. The characteristics of Ad transduction include: the relative ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ba6b4114b036750b0e239a4e3d5fff7
https://doi.org/10.1016/s0165-0270(96)00128-8
https://doi.org/10.1016/s0165-0270(96)00128-8
Autor:
Elise Peltekian, Luis Garcia, Nathalie Samson-Desvignes, Glenn Dallérac, Cyrille Vaillend, Pascale Leblanc-Veyrac, Jean-Marie Billard, Caroline Perronnet, Serge Laroche, Carine Chagneau, Olivier Danos
Publikováno v:
Neurobiology of Disease
Neurobiology of Disease, Elsevier, 2011, 43 (3), pp.635-641. ⟨10.1016/j.nbd.2011.05.012⟩
Neurobiology of Disease, Vol 43, Iss 3, Pp 635-641 (2011)
Neurobiology of Disease, 2011, 43 (3), pp.635-641. ⟨10.1016/j.nbd.2011.05.012⟩
Neurobiology of Disease, Elsevier, 2011, 43 (3), pp.635-641. ⟨10.1016/j.nbd.2011.05.012⟩
Neurobiology of Disease, Vol 43, Iss 3, Pp 635-641 (2011)
Neurobiology of Disease, 2011, 43 (3), pp.635-641. ⟨10.1016/j.nbd.2011.05.012⟩
International audience; Duchenne muscular dystrophy (DMD) is caused by the absence of dystrophin, a protein that fulfills important functions in both muscle and brain. The mdx mouse model of DMD, which also lacks dystrophin, shows a marked reduction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5564062d77039027e3551a10810761fd
https://hal-normandie-univ.archives-ouvertes.fr/hal-02325193
https://hal-normandie-univ.archives-ouvertes.fr/hal-02325193
Autor:
Patrick A. Dreyfus, Axel Kahn, Said Akli, E. Vigne, Michel Perricaudet, C. Bouchard, Elise Peltekian, Marc Peschanski, Fabrice Lisovoski, G. Haase
Publikováno v:
Restorative neurology and neuroscience. 8(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b79f5ab50cb7f482b2ba159abb99255e
https://pubmed.ncbi.nlm.nih.gov/21551805
https://pubmed.ncbi.nlm.nih.gov/21551805
Autor:
Olivier Danos, Carole Gruszczynski, Luis Garcia, Cyrille Vaillend, Carine Ros, Caroline Perronnet, Elise Peltekian, Aurélie Goyenvalle, Serge Laroche
Publikováno v:
Molecular Therapy
Molecular Therapy, Cell Press, 2010, 18 (9), pp.1683-8. ⟨10.1038/mt.2010.134⟩
Molecular Therapy, Nature Publishing Group, 2010, 18 (9), pp.1683-8. 〈10.1038/mt.2010.134〉
Molecular Therapy, 2010, 18 (9), pp.1683-8. ⟨10.1038/mt.2010.134⟩
Molecular Therapy, Nature Publishing Group, 2010, 18 (9), pp.1683-8. ⟨10.1038/mt.2010.134⟩
Molecular Therapy, Cell Press, 2010, 18 (9), pp.1683-8. ⟨10.1038/mt.2010.134⟩
Molecular Therapy, Nature Publishing Group, 2010, 18 (9), pp.1683-8. 〈10.1038/mt.2010.134〉
Molecular Therapy, 2010, 18 (9), pp.1683-8. ⟨10.1038/mt.2010.134⟩
Molecular Therapy, Nature Publishing Group, 2010, 18 (9), pp.1683-8. ⟨10.1038/mt.2010.134⟩
International audience; Dystrophin, the cytoskeletal protein whose defect is responsible for Duchenne muscular dystrophy (DMD), is normally expressed in both muscles and brain. Genetic loss of brain dystrophin in the mdx mouse model of DMD reduces th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f295ef525e906cdda3fc9bf68967a0
https://hal.archives-ouvertes.fr/hal-01183355
https://hal.archives-ouvertes.fr/hal-01183355